BEXSERO®

BEXSERO is contraindicated in cases of hypersensitivity, including severe allergic reaction, to any component of the vaccine, or after a previous dose of BEXSERO

...continue reading

Only BEXSERO provides the fastest MenB series completion with 2 doses administered in as little as 1 month."toolbar=yes, scrollbars=yes, resizable=yes, width=400, height=400,top=50, left=50"[8]

With 2 doses of BEXSERO administered at least 1 month apart, you can help fill the gap in protection against meningococcal group B."toolbar=yes, scrollbars=yes, resizable=yes, width=400, height=400,top=50, left=50"[8]

  • The dosing schedule for BEXSERO allows your patients to complete the series within the span of 1 typical summer break
  • BEXSERO comes in a prefilled syringe and is administered by intramuscular injection

The tip caps of the prefilled syringes contain natural rubber latex, which may cause allergic reactions in latex-sensitive individuals.

BEXSERO is a vaccine consisting of 4 antigens—fHbp, NadA, NHBA, and PorA P1.4 (present in OMV).

fHbp=factor H binding protein; NadA=Neisserial adhesin A; NHBA=Neisserial Heparin Binding Antigen; PorA P1.4 present in Outer Membrane Vesicles (OMV).

References

"toolbar=yes, scrollbars=yes, resizable=yes, width=400, height=400,top=50, left=50"View all references

709301R0 May 2016